Program Leadership

Gastrointestinal Malignancies Program

The DF/HCC GI Program welcomes clinicians and investigators seeking to unravel the pathogenesis and pathophysiology of GI cancers, to understand genetic and environmental risk factors, and to design and implement novel strategies for diagnosis, treatment and prevention.  We bring together over 80 basic, clinical and population science investigators from all institutions of the DF/HCC.   The Program has a broad and open focus on GI cancers including colorectal, pancreas, esophagus, stomach, small intestine, anus, biliary tract, liver and neuroendocrine lineages within these organ systems.  

Five specific aims were outlined in the Comprehensive Cancer Support Grant (CCSG), however the program encourages and supports collaborative investigation in all areas of GI cancer research, treatment and prevention

Program Updates